Toggle topbar
北京大学国家发展研究院

劳动与健康经济学workshop:Strategic Behavior and Entry Deterrence by Branded Drug Firms: The Case of Authorized Generic Drugs

发布日期：2022-12-16 12:00    来源：

时间：2022年12月16日（周五）10:00-11:30

会议形式：线上举行（发送自我简介至邮箱 xlgao@nsd.pku.edn.cn 获取线上会议信息）

主持人：雷晓燕、易君健

参与老师：赵耀辉、李玲、刘国恩、张丹丹、黄炜

主讲人：姚璐，中国政法大学商学院

摘要：Pharmaceutical firms that market brand name drugs lose substantial market share to generic manufacturers after patent expiration. As a response to the threat of generic competition, branded manufacturers pursue defensive strategies. One such strategy is the launch of authorized generic drugs. Autho- rized generic drugs are produced by branded manufacturers to compete against other generic drug entrants. Such competition may lower the expected profits of generic drug manufacturers and hence deter future generic drug entry. This paper models and empirically examines whether the introduction of authorized generic drugs changes the independent generic firms’ decisions on entering the market. We use an instrumental variable approach to evaluate the effect of authorized generic drugs on the responses of generic manufacturers. The results show that the entry of authorized generic drugs deters and delays the entry of generic drugs.

 

主讲人简介：姚璐，中国政法大学商学院讲师。2020年毕业于美国杜兰大学。主要研究方向为健康经济学和产业组织。


分享到：
朗润

国家发展研究院官方微信

国家发展研究院官方微信
点击关注点击关注

相关链接

Copyright© 1994-2012 北京大学 国家发展研究院 版权所有, 京ICP备05065075号-1
保留所有权利，不经允许请勿挪用